Halozyme Therapeutics shares owned by Metatron Capital SICAV plc - Metatron Long Term Equity Fund
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Metatron Capital SICAV plc - Metatron Long Term Equity Fund
from 13F filings
Historical chart of Metatron Capital SICAV plc - Metatron Long Term Equity Fund investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Metatron Capital SICAV plc - Metatron Long Term Equity Fund consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Metatron Capital SICAV plc - Metatron Long Term Equity Fund
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $2.7M | 34k | 78.27 |
More positions owned by Metatron Capital SICAV plc - Metatron Long Term Equity Fund
View all positions for Metatron Capital SICAV plc - Metatron Long Term Equity Fund